1. Home
  2. CAE vs CORT Comparison

CAE vs CORT Comparison

Compare CAE & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

N/A

Current Price

$28.67

Market Cap

8.5B

Sector

N/A

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$81.88

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAE
CORT
Founded
1947
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CAE
CORT
Price
$28.67
$81.88
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$33.75
$130.20
AVG Volume (30 Days)
579.5K
821.3K
Earning Date
11-11-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.97
0.87
Revenue
$3,470,482,234.00
$741,172,000.00
Revenue This Year
$6.40
$23.79
Revenue Next Year
$5.69
$40.97
P/E Ratio
$29.80
$92.87
Revenue Growth
9.12
17.92
52 Week Low
$20.36
$49.00
52 Week High
$30.13
$117.33

Technical Indicators

Market Signals
Indicator
CAE
CORT
Relative Strength Index (RSI) 60.18 51.62
Support Level $27.07 $78.07
Resistance Level $30.08 $89.00
Average True Range (ATR) 0.67 3.40
MACD 0.26 -0.11
Stochastic Oscillator 60.00 39.42

Price Performance

Historical Comparison
CAE
CORT

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: